首页> 外文期刊>Cardio-oncology. >Clinical outcomes after transcatheter aortic valve replacement in cancer survivors treated with ionizing radiation
【24h】

Clinical outcomes after transcatheter aortic valve replacement in cancer survivors treated with ionizing radiation

机译:经截觉管主动脉瓣膜置换术后癌症幸存者的临床结果,电离辐射治疗

获取原文
       

摘要

Improved cancer survival in patients treated with thoracic ionizing radiation (XRT) has resulted in unanticipated surge of aortic stenosis. Transcatheter aortic valve replacement (TAVR) has revolutionized the management of severe aortic stenosis. However, long-term clinical outcomes in radiation-exposed cohorts undergoing TAVR are unknown. We compared the all-cause mortality and major adverse cardiac events (MACE) in patients with prior chest XRT (C-XRT) undergoing TAVR. This is an observational cohort study in subjects who underwent TAVR for symptomatic severe aortic stenosis from 2012 to 2017 in a tertiary care referral center. We examined the all-cause mortality and MACE using cox proportional hazard analysis to identify the clinical predictors of survival in the cohort of patients who had a history of prior C-XRT for malignancy. Of the 610 patients who underwent TAVR for symptomatic severe aortic stenosis, 75 had prior C-XRT. The majority of C-XRT patients had prior breast cancer (44%) followed by Hodgkin’s lymphoma (31%), with the median time from XRT to TAVR of 19.0?years. During a mean follow up of 17.1?months after TAVR, all-cause mortality was 17%. Those with prior C-XRT had higher all-cause mortality (XRT: 29%; non-XRT:15%, p??0.01) and MACE (XRT: 57%; non-XRT: 27%, p??0.001) after TAVR. Patients with prior XRT had a higher incidence of atrial fibrillation (XRT: 48%; non-XRT: 2.4%, p??0.01) and high-grade heart block (XRT: 20%; non-XRT: 9.1%, p?=?0.007) requiring pacemaker implant after TAVR. On multivariate cox proportional hazard analysis, prior XRT (HR: 2.07, p?=?0.003), poor renal function (HR: 1.29, p??0.001) and post-operative anemia requiring transfusion (HR: 1.16, p:0.001) were the strongest predictors of reduced survival. Cancer survivors with prior C- XRT have higher incidence of all-cause mortality and MACE after TAVR. Careful patient selection and follow-up strategies are needed to improve outcomes.
机译:通过胸部电离辐射(XRT)治疗的患者的改善癌症存活导致主动脉狭窄的意外涌动。经齿轮管主动脉瓣更换(TAVR)彻底改变了严重主动脉狭窄的管理。然而,经历TAVR的辐射暴露的队列中的长期临床结果是未知的。我们将患有胸部XRT(C-XRT)的患者患者进行了比较了全因死亡率和主要不良心脏事件(MACE)。这是在第三次护理转诊中心的2012年至2017年患有2012年至2017年症状严重主动脉狭窄的受试者的观察队列研究。我们检查了使用Cox比例危害分析的全因死亡率和均匀,以确定患有患者患者的临床预测因子,该患者患有死亡率的恶性肿瘤的患者。在接受症状严重主动脉狭窄的610名患者中,75例先前C-XRT。大多数C-XRT患者患有乳腺癌(44%),其次是Hodgkin的淋巴瘤(31%),中位数从XRT到TAVR为19.0?年。在平均随访17.1?TAVR后几个月,全因死亡率为17%。那些具有先前的C-XRT的死亡率较高(XRT:29%;非XRT:15%,P?<?0.01)和MACE(XRT:57%;非XRT:27%,P?<? TAVR后0.001)。先前XRT的患者具有更高的心房颤动发病率(XRT:48%;非XRT:2.4%,P?<?0.01)和高级心脏块(XRT:20%;非XRT:9.1%,P ?= 0.007)在TAVR之后需要起搏器植入。在多元COX比例危险分析中,先前XRT(HR:2.07,P?= 0.003),肾功能不良(HR:1.29,P?0.001)和术后贫血需要输血(HR:1.16,P:0.001 )是减少存活率的最强预测因子。癌症幸存者具有先前的C-XRT在TAVR后具有较高的全导致死亡率和立柱的发病率。需要仔细的患者选择和后续策略来改善结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号